URMC Logo

URMC / Research / Research@URMC
Seeking new treatments for Fragile X syndrome

Seeking new treatments for Fragile X syndrome

Fragile X is the most common known cause of inherited intellectual disability and autism. There is no cure, but scientists at the School of Medicine and Dentistry are joining the search for new and effective treatments.

6/8/2015 | 0 comments
Cardiac Trainee Wins Young Investigator Award from American Physiological Society

Cardiac Trainee Wins Young Investigator Award from American Physiological Society

David Auerbach, Ph.D., a trainee at the Aab Cardiovascular Research Institute, won the Clinical Science Young Investigator Award – Cardiovascular Section from the American Physiological Society, which recognizes an outstanding junior investigator involved in cardiovascular research. 

4/14/2015 | 0 comments
Meds for ADHD, Depression Dangerous in Patients with Heart Rhythm Disorder

Meds for ADHD, Depression Dangerous in Patients with Heart Rhythm Disorder

Last week, several members of URMC’s Heart Research Follow-up team presented new research at the American Heart Association’s Annual Scientific Sessions in Dallas. Among the findings – medications for ADHD and depression are dangerous in patients with Long QT syndrome, a disorder that makes the heart particularly susceptible to arrhythmias.  

11/26/2013 | 1 comment
Science Spotlight: Meet Michael T. Sellix, Ph.D.

Science Spotlight: Meet Michael T. Sellix, Ph.D.

Sellix, an assistant professor in the Division of Endocrinology and Metabolism, studies circadian rhythms and biological clocks. He was recently awarded the 2013 Early Investigators Award by the Endocrine Society. Check out this video to learn more about his current and future research. 

8/27/2013 | 0 comments